How should cardiac xenotransplantation be initiated in Japan?

Saito, Shunsuke; Miyagawa, Shuji; Kawamura, Takuji; Yoshioka, Daisuke; Kawamura, Masashi; Kawamura, Ai; Misumi, Yusuke; Taguchi, Takura; Yamauchi, Takashi; Miyagawa, Shigeru

doi:https://doi.org/10.1007/s00595-024-02861-7

How should cardiac xenotransplantation be initiated in Japan?

Saito, Shunsuke; Miyagawa, Shuji; Kawamura, Takuji et al.

Surgery Today, 2024

アクセス数:48件（2025-04-21 08:29 集計）

固定URL: https://hdl.handle.net/11094/97115

閲覧可能ファイル

ファイル	フォーマット	利用条件	サイズ	閲覧回数	利用開始日	説明	information
SurgToday_s00595_024_02861_7	pdf	なし	861 KB	39	2024.07.05

Creative Commons : 表示

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

タイトル	How should cardiac xenotransplantation be initiated in Japan?
著者	NRID 1000030600126 1000030600126 ORCID 0000-0002-0829-2891 0000-0002-0829-2891 researchmap permalink shunsaito shunsaito Scopus Author ID 57205524320 57205524320 著者名 Saito, Shunsuke
	NRID 1000090273648 1000090273648 researchmap permalink read0185079 read0185079 著者名 Miyagawa, Shuji
	NRID 1000060839398 1000060839398 researchmap permalink takuji-kawamura takuji-kawamura Scopus Author ID 55331768500 55331768500 著者名 Kawamura, Takuji
	NRID 1000040645959 1000040645959 researchmap permalink d-yoshioka d-yoshioka Scopus Author ID 7003892845 7003892845 著者名 Yoshioka, Daisuke
	NRID 1000070583011 1000070583011 researchmap permalink mk_mk mk_mk 著者名 Kawamura, Masashi
	NRID 1000010838923 1000010838923 researchmap permalink a-kawamura a-kawamura Scopus Author ID 56414159900 56414159900 著者名 Kawamura, Ai
	NRID 1000020631477 1000020631477 researchmap permalink yusukemisumi yusukemisumi 著者名 Misumi, Yusuke
	著者名 Taguchi, Takura
	NRID 1000020527999 1000020527999 著者名 Yamauchi, Takashi
	NRID 1000070544237 1000070544237 ORCID 0000-0003-0015-6569 0000-0003-0015-6569 researchmap permalink s-miyagawa3154 s-miyagawa3154 Scopus Author ID 55560624700 55560624700 著者名 Miyagawa, Shigeru
キーワード等	Cardiac xenotransplantation
	End-stage heart failure
	Genetic engineering
	Hyperacute rejection
	Pig
内容	The version of record of this article, first published in Surgery Today, is available online at Publisher’s website: https://doi.org/10.1007/s00595-024-02861-7.
抄録	The world's first clinical cardiac xenotransplantation, using a genetically engineered pig heart with 10 gene modifications, prolonged the life of a 57-year-old man with no other life-saving options, by 60 days. It is foreseeable that xenotransplantation will be introduced in clinical practice in the United States. However, little clinical or regulatory progress has been made in the field of xenotransplantation in Japan in recent years. Japan seems to be heading toward a "device lag", and the over-importation of medical devices and technology in the medical field is becoming problematic. In this review, we discuss the concept of pig-heart xenotransplantation, including the pathobiological aspects related to immune rejection, coagulation dysregulation, and detrimental heart overgrowth, as well as genetic modification strategies in pigs to prevent or minimize these problems. Moreover, we summarize the necessity for and current status of xenotransplantation worldwide, and future prospects in Japan, with the aim of initiating xenotransplantation in Japan using genetically modified pigs without a global delay. It is imperative that this study prompts the initiation of preclinical xenotransplantation research using non-human primates and leads to clinical studies.
出版者	Springer
収録物名	Surgery Today
刊行年月	2024-05-11
言語	英語
ハンドルURL	https://hdl.handle.net/11094/97115
PISSN	09411291
eISSN	14362813
関連情報 (isIdenticalTo)	DOI (出版社版) https://doi.org/10.1007/s00595-024-02861-7
アクセス権	open access
権利情報	This article is licensed under a Creative Commons Attribution 4.0 International License.
出版タイプ	Version of Record
カテゴリ	学術雑誌論文 Journal Article

資源タイプ	学術雑誌論文
ローカル資源タイプ	学術雑誌論文
DCTERMS.bibliographicCitation	Surgery Today. 2024
DC.title	How should cardiac xenotransplantation be initiated in Japan?
DC.creator	Saito, Shunsuke
	Miyagawa, Shuji
	Kawamura, Takuji
	Yoshioka, Daisuke
	Kawamura, Masashi
	Kawamura, Ai
	Misumi, Yusuke
	Taguchi, Takura
	Yamauchi, Takashi
	Miyagawa, Shigeru
DC.publisher	Springer
DC.language' scheme='DCTERMS.RFC1766	英語
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2024-05-11
DC.identifier	https://doi.org/10.1007/s00595-024-02861-7
DC.subject	Cardiac xenotransplantation
	End-stage heart failure
	Genetic engineering
	Hyperacute rejection
	Pig
DC.description	The version of record of this article, first published in Surgery Today, is available online at Publisher’s website: https://doi.org/10.1007/s00595-024-02861-7.
DCTERMS.abstract	The world's first clinical cardiac xenotransplantation, using a genetically engineered pig heart with 10 gene modifications, prolonged the life of a 57-year-old man with no other life-saving options, by 60 days. It is foreseeable that xenotransplantation will be introduced in clinical practice in the United States. However, little clinical or regulatory progress has been made in the field of xenotransplantation in Japan in recent years. Japan seems to be heading toward a "device lag", and the over-importation of medical devices and technology in the medical field is becoming problematic. In this review, we discuss the concept of pig-heart xenotransplantation, including the pathobiological aspects related to immune rejection, coagulation dysregulation, and detrimental heart overgrowth, as well as genetic modification strategies in pigs to prevent or minimize these problems. Moreover, we summarize the necessity for and current status of xenotransplantation worldwide, and future prospects in Japan, with the aim of initiating xenotransplantation in Japan using genetically modified pigs without a global delay. It is imperative that this study prompts the initiation of preclinical xenotransplantation research using non-human primates and leads to clinical studies.
DC.rights	This article is licensed under a Creative Commons Attribution 4.0 International License.
DC.format	97115
citation_title	How should cardiac xenotransplantation be initiated in Japan?
citation_author	Saito, Shunsuke
	Miyagawa, Shuji
	Kawamura, Takuji
	Yoshioka, Daisuke
	Kawamura, Masashi
	Kawamura, Ai
	Misumi, Yusuke
	Taguchi, Takura
	Yamauchi, Takashi
	Miyagawa, Shigeru
citation_publisher	Springer
citation_language	英語
citation_date	2024-05-11
citation_journal_title	Surgery Today
citation_doi	https://doi.org/10.1007/s00595-024-02861-7
citation_public_url	https://hdl.handle.net/11094/97115

How should cardiac xenotransplantation be initiated in Japan?

閲覧可能ファイル

論文情報

論文詳細を表示